Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Cronos Group Inc. (T:CRON)

Business Focus: Alternative Medicine

INK Edge Outlook

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for CRON within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Dec 11, 2020 12:00 ET
Cronos Group Inc. to Present at the MKM Partners Virtual Conference
Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Executive Chairman, will present at The Road Ahead, Preparation for 2021: MKM Partners...
Read full article
Nov 25, 2020 14:00 ET
Cronos Group Inc. to Speak at the Cowen 2020 Boston Cannabis Conference
Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Executive Chairman, is scheduled to speak on a panel at the Cowen 2020 Boston Cannabis...
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
2.16
--
--
Price to Sales - TTM
93.51
10.56
12.51
Price to Book - most recent quarter
1.97
2.97
4.00
Price to Cash Flow per share - TTM
33.08
16.46
16.26
Price to Free Cash Flow per share - TTM
--
30.93
27.60
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Dec 31, 20203,673,913-186,949
Dec 15, 20203,860,862-2,335,316
Nov 30, 20206,196,17824,566
See Short Report

Business Summary

Sector:  Healthcare Industry:  Pharmaceuticals

Cronos Group Inc is a cannabinoid company. The Company is focused on cannabis research, technology and product development. The Company's portfolio includes PEACE NATURALS, COVE, Spinach, Lord Jones and PEACE+. PEACE NATURALS a global wellness platform. The COVE and Spinach are adult-use brands. The Lord Jones and PEACE+ are hemp-derived cannabidiol (CBD) brands. The Company's segments include United States and Rest of World. The United States segment consists of the manufacture and distribution of hemp-derived CBD infused products. The Rest of World operating segment is involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. The Company's subsidiaries include Cronos Israel G.S. Cultivations Ltd, Cronos Israel G.S. Manufacturing Ltd, Cronos Israel G.S. Store Ltd and Cronos Israel G.S. Pharmacies Ltd.

See business summary

 

Twitter

Search (past week) for $CRON.CA

  • No tweets found